Cargando…

Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015

BACKGROUND: Serogroup W (NmW) meningococcal disease is a rare but severe infection. Following an NmW outbreak after the Hajj in 2000, NmW disease, predominantly caused by sequence type (ST)-11 clonal complex (cc), rapidly increased in South Africa, South America, and the UK. We describe NmW meningoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Soeters, Heidi, Blain, Amy, Chang, How-Yi, Whaley, Melissa, Macneil, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632085/
http://dx.doi.org/10.1093/ofid/ofx162.017
_version_ 1783269630658215936
author Soeters, Heidi
Blain, Amy
Chang, How-Yi
Whaley, Melissa
Macneil, Jessica
author_facet Soeters, Heidi
Blain, Amy
Chang, How-Yi
Whaley, Melissa
Macneil, Jessica
author_sort Soeters, Heidi
collection PubMed
description BACKGROUND: Serogroup W (NmW) meningococcal disease is a rare but severe infection. Following an NmW outbreak after the Hajj in 2000, NmW disease, predominantly caused by sequence type (ST)-11 clonal complex (cc), rapidly increased in South Africa, South America, and the UK. We describe NmW meningococcal disease epidemiology in the USA during 2010–2015. METHODS: Data were collected from the National Notifiable Diseases Surveillance System, Active Bacterial Core surveillance, and state health departments. Isolates were serogrouped via slide agglutination and real-time polymerase chain reaction. For cases lacking a serogroup result at CDC, the state result was used. Case-fatality ratios (CFR) were calculated using the proportion of cases with known outcomes as the denominator. cc and ST were determined using multilocus sequence typing (MLST). RESULTS: From 2010 to 2015, 3,504 meningococcal disease cases were reported to CDC; 2,976 (85%) had a serogroup result, of which 290 (10%) were NmW. Although the number of NmW cases reported annually remained fairly stable (range: 40–57), the total number of reported meningococcal disease cases decreased by 60%, and the proportion of cases due to NmW increased from 6% (42/830) in 2010 to 12% (40/332) in 2015. The majority of NmW cases were reported from five states: Florida (n = 106), California (n = 31), New York (n = 25), Georgia (n = 19), and Oregon (n = 11). Half of people with NmW disease were male, 185 (64%) were white, and 84 (29%) were Hispanic. The median age was 51 years (interquartile range: 26–70). Overall, 20% (52/259) of NmW cases were fatal, compared with CFRs for serogroups B (15%), Y (18%), or C (24%). NmW CFR was highest among adults aged 50–59 years (38%). MLST results were available for 119 (41%) of NmW cases: 76 (64%) were cc11, 40 (34%) were cc22, and 1 each were cc23, cc32, and an unassigned cc. cc appeared to be geographically associated: cc11 was concentrated in Florida and Georgia, while cc22 predominated on the West coast. Within cc11, the majority of isolates (86%) were ST-11, and within cc22 the majority (73%) were ST-22. CONCLUSION: A rapid increase in NmW disease has not been observed in the USA. Most NmW cases were reported in a limited number of states, with geographic differences in clonal complex. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5632085
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56320852017-11-07 Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015 Soeters, Heidi Blain, Amy Chang, How-Yi Whaley, Melissa Macneil, Jessica Open Forum Infect Dis Abstracts BACKGROUND: Serogroup W (NmW) meningococcal disease is a rare but severe infection. Following an NmW outbreak after the Hajj in 2000, NmW disease, predominantly caused by sequence type (ST)-11 clonal complex (cc), rapidly increased in South Africa, South America, and the UK. We describe NmW meningococcal disease epidemiology in the USA during 2010–2015. METHODS: Data were collected from the National Notifiable Diseases Surveillance System, Active Bacterial Core surveillance, and state health departments. Isolates were serogrouped via slide agglutination and real-time polymerase chain reaction. For cases lacking a serogroup result at CDC, the state result was used. Case-fatality ratios (CFR) were calculated using the proportion of cases with known outcomes as the denominator. cc and ST were determined using multilocus sequence typing (MLST). RESULTS: From 2010 to 2015, 3,504 meningococcal disease cases were reported to CDC; 2,976 (85%) had a serogroup result, of which 290 (10%) were NmW. Although the number of NmW cases reported annually remained fairly stable (range: 40–57), the total number of reported meningococcal disease cases decreased by 60%, and the proportion of cases due to NmW increased from 6% (42/830) in 2010 to 12% (40/332) in 2015. The majority of NmW cases were reported from five states: Florida (n = 106), California (n = 31), New York (n = 25), Georgia (n = 19), and Oregon (n = 11). Half of people with NmW disease were male, 185 (64%) were white, and 84 (29%) were Hispanic. The median age was 51 years (interquartile range: 26–70). Overall, 20% (52/259) of NmW cases were fatal, compared with CFRs for serogroups B (15%), Y (18%), or C (24%). NmW CFR was highest among adults aged 50–59 years (38%). MLST results were available for 119 (41%) of NmW cases: 76 (64%) were cc11, 40 (34%) were cc22, and 1 each were cc23, cc32, and an unassigned cc. cc appeared to be geographically associated: cc11 was concentrated in Florida and Georgia, while cc22 predominated on the West coast. Within cc11, the majority of isolates (86%) were ST-11, and within cc22 the majority (73%) were ST-22. CONCLUSION: A rapid increase in NmW disease has not been observed in the USA. Most NmW cases were reported in a limited number of states, with geographic differences in clonal complex. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632085/ http://dx.doi.org/10.1093/ofid/ofx162.017 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Soeters, Heidi
Blain, Amy
Chang, How-Yi
Whaley, Melissa
Macneil, Jessica
Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
title Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
title_full Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
title_fullStr Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
title_full_unstemmed Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
title_short Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
title_sort current epidemiology of serogroup w meningococcal disease—united states, 2010–2015
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632085/
http://dx.doi.org/10.1093/ofid/ofx162.017
work_keys_str_mv AT soetersheidi currentepidemiologyofserogroupwmeningococcaldiseaseunitedstates20102015
AT blainamy currentepidemiologyofserogroupwmeningococcaldiseaseunitedstates20102015
AT changhowyi currentepidemiologyofserogroupwmeningococcaldiseaseunitedstates20102015
AT whaleymelissa currentepidemiologyofserogroupwmeningococcaldiseaseunitedstates20102015
AT macneiljessica currentepidemiologyofserogroupwmeningococcaldiseaseunitedstates20102015